Table 1 Biochemical, immunologic, metabolic, and serological investigations

Complete blood count

 WBC

3 × 10³

U/L

4–11

 Hemoglobin

10.5

g/dl

11–16

 Hematocrit

31.2

%

33–44

 Red cell count

3.41 × 10⁶

UL

3.8–5.4

 MCV

91.5

Fl

78–96

 MCH

30.8

Pg

26–32

 MCHC

33.7

g/dl

31–36

 RDW

13.4

%

11.5–14.5

 Platelets

140 × 103

U/L

150–450

Differential count

 Basophils

1

%

0–1

 Eosinophils

0

%

0–3

 Stab

0

%

0–7

 Segmented

66

%

40–75

 Lymphocytes

29

%

20–40

 Monocytes

4

%

1–10

 Potassium

3.4

mmol/l

3.5–5

 Sodium

14

mEq/

135–145

 Calcium ionized

1.10

mmol/l

1.2–1.4

 ALT

68

u/l

14–63

 AST

54

u/l

15–37

 S. ammonia

0.3

mg/dl

0.17–0.8

 S. creatinine

0.4

mg/dl

0.55–1.3

 RBS

118

mg/dl

74–106

 BUN

17

mg/dl

7–18

 Total bilirubin

0.239

mg/dl

0.20–1.00

 CRP

2

mg/l

> 5

 S. troponin

Zero

ng/ml

> 0.02

 CK-MB

15

IU/L

20–200

 Free T3

2.47

pg/ml

1.58–6.91

 Free T4

1.09

ng/dl

0.7–1.48

 TSH

1.747

u/Uml

0.55–4.78

 S.PTH

32.0

Pg/ml

15–68

 Anti-nuclear Ab (ANA)

Nuclear pattern

Negative

Cytoplasmic pattern

Negative

Mitotic pattern

Negative

HSV-1 IgG

15.8

< 9 negative

9–11 equivocal

> 11 positive

HSV-1 V IgM

1.2

< 9 negative

9–11 equivocal

> 11 positive

HSV-2 IgG

1.3

< 9 negative

9–11 equivocal

> 11 positive

HSV-2 IgM

1.7

< 9 negative

9–11 equivocal

> 11 positive

CMV Ab IgG

37.2

Negative up to 6

CMV Ab IgM

3.2

Negative < 18

Intermediate < 22

Positive > 22

EBV VCA IgM

55.6

Up to 150 negative

150–180 cutoff

> 180 positive

EBV-VCA-IgG

118 µ/ml

Up to 150 negative

150–180 cutoff

Over 180 positive